Sort
10,766 grants matching “checkpoint inhibitor”
Immunobiology and Immunotherapy of Pediatric Tumors
$1,284,838Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
NYU BIOMARKER CLINICAL AND EPIDEMIOLOGIC CENTER
$1,283,443New York University School Of Medicine · U01 · FY2003 · CA
Preclinical GEM and GDA Models of Primary and Metastatic Melanoma
$1,283,220Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Therapeutic evaluation in ovarian and breast cancer GEMGDA models
$1,283,220Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Modification of hyperthermia response
$1,281,745Thomas Jefferson University · P01 · FY2004 · CA
Mechanism and Regulation Of Eukaryotic Protein Synthesis
$1,281,105Thomas E Dever · Child Health And Human Development · Z01 · FY2007 · HD
Design of Drugs Against Cancer and Viral Diseases
$1,280,818Christopher Michejda · Basic Sciences · Z01 · FY2007 · CA
Uncovering the metabolic underpinnings of T cell exhaustion
$1,280,768Greg M. Delgoffe · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
Phase I therapeutic testing of viral-vectored vaccines that shift CD8+ T cell immunodominance to conserved regions of HIV-1
$1,279,617Nilu Goonetilleke · Univ Of North Carolina Chapel Hill · U01 · FY2020 · AI
Function of RecQ helicases in genome stability
$1,278,003Vilhelm A Bohr · National Institute On Aging · ZIA · FY2014 · AG
Clinical and Mechanistic Investigations of Salivary Gland Dysfunction
$1,277,652Blake Warner · National Institute Of Dental & Craniofacial Research · ZIA · FY2020 · DE
Extracellular Vesicles (EVs) and Genes in the Biology and Therapy of Gliomas
$1,277,211Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2019 · CA
Studies of Receptor Interactions and Effects of Alarmins
$1,276,907Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Photodynamic Priming of Cancer and Image-guidance for Optimal Immune Response
$1,274,917Tayyaba Hasan · Massachusetts General Hospital · P01 · FY2022 · CA
Modification of hyperthermia response
$1,274,540Thomas Jefferson University · P01 · FY2003 · CA
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
$1,272,540Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Preclinical drug development in pancreatic cancer
$1,268,802Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Cachexia-mediated FcRn Modulation and Its Impact on Anti-PD1 Therapy in Lung Cancer
$1,263,739Mitch A Phelps · Ohio State University · R01 · FY2025 · CA
Center for Interventional Oncology
$1,263,405Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2025 · CA
A phase I study of RNA-lipid particle vaccines for newly-diagnosed glioblastoma, IND19304 08/21/2020
$1,262,498Elias Sayour · University Of Florida · R01 · FY2022 · FD
Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging
$1,260,626Steven Hou · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Center for Lupus Research
$1,259,044Maria Virginia Pascual · Baylor Research Institute · P50 · FY2006 · AR
NYU BIOMARKER CLINICAL AND EPIDEMIOLOGIC CENTER
$1,256,115New York University School Of Medicine · U01 · FY2004 · CA
Center for Interventional Oncology
$1,254,568Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2022 · CA
NYU BIOMARKER CLINICAL AND EPIDEMIOLOGIC CENTER
$1,253,944New York University School Of Medicine · U01 · FY2002 · CA